Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Xped is a health information services business based in Australia. Xped shares (XPE) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Xped has a trailing 12-month revenue of around $1.9 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Xped
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Xped . Find the share by name or ticker symbol: XPE. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Xped reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Xped . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
ETF investing
Our top pick for
Long-term investing
Xped stock price (ASX:XPE)
Use our graph to track the performance of XPE stocks over time.Xped shares at a glance
Information last updated 2021-06-22.
| 52-week range | $0.001 - $0.004 |
|---|---|
| 50-day moving average | $0.0023 |
| 200-day moving average | $0.002 |
| Target price | $0.48 |
| PE ratio | 0 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.002 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Xped stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Xped price performance over time
Historical closes compared with the last close of A$0.002
| 1 year (2021-01-15) | -33.33% |
|---|---|
| 2 years (2020-01-16) | 100.00% |
| 3 years (2019-01-16) | -20.00% |
| 5 years (2017-01-16) | -98.33% |
Is Xped under- or over-valued?
Valuing Xped stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Xped 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Xped 's EBITDA
Xped 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $399,611 (£210,625).
The EBITDA is a measure of a Xped 's overall financial performance and is widely used to measure a its profitability.
Xped financials
| Revenue TTM | $1.9 million |
|---|---|
| Operating margin TTM | 19.69% |
| Gross profit TTM | $1.5 million |
| Return on assets TTM | 18.23% |
| Return on equity TTM | 39.89% |
| Profit margin | 10.68% |
| Book value | 0 |
| Market capitalisation | $6.4 million |
TTM: trailing 12 months
Xped share dividends
We're not expecting Xped to pay a dividend over the next 12 months.
Have Xped 's shares ever split?
Xped 's shares were split on a 1:2 basis on 31 May 2017. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Xped shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for Xped shares which in turn could have impacted Xped 's share price.
Xped share price volatility
Over the last 12 months, Xped 's shares have ranged in value from as little as $0.001 up to $0.004. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Xped 's is -0.865. This would suggest that Xped 's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Xped has bucked the trend.
Xped overview
Xped Limited develops Internet of Things technology solutions for consumer, commercial, industrial, and healthcare markets. It operates through Healthcare Technology, Technology Development, and Geothermal Projects segments. The company offers DiscoverBus wireless sensor network designed to create secure indoor wireless networks for smart office, smart building, industrial, and commercial applications; and DiscoverBus wired hub and node network primarily designed for wired networks for smart office, smart building, industrial, and commercial applications. It also provides Smart Home Gateway to automate, monitor, and control home; communication technology solutions, including the development and distribution of range of nurse call hardware and software solutions for use in hospitals, aged care, disability care, and supported independent living; and operates various geothermal projects. The company is based in Payneham, Australia.
Xped in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
RAT scams: How to avoid getting conned with rapid antigen tests
Don't fall for the scam artists when you're trying to protect your health - here's what to check.
-
How to do a COVID-19 test at home for international travel
Here's where you can book COVID-19 at-home tests approved for travel and how they work.
-
Where to shop every product in Kiernan Shipka’s beauty routine
We've rounded up everything you need to nail the 'date-worthy' makeup look, including some affordable dupes.
-
American Express Corporate Gold Card
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
-
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
-
Beauty Product of the Week: Milk Makeup Hydro Grip Primer
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
-
Where to watch Hotel Transylvania 4 online for free in Australia
Drac and the Pack are back, like you’ve never seen them before.
-
Dyson V12 Detect Slim review: Baby love, my baby love
A delightful compact vacuum with an unjustifiable price.
-
Stan Event: Streaming platform joins pay-per-view ranks
A new player enters the Australian sports broadcast market.
-
Amazon Echo Buds (2nd Gen) review: Fine if you’re already trapped by Bezos
The Amazon Echo Buds 2 are a solid addition to your earholes if you’re already integrated in the Alexa ecosystem. But if you’re not, its hard to find anything here that really stands out.
Ask an Expert
